Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4+ T cell apoptosis

Carbohydr Polym. 2020 Nov 1:247:116728. doi: 10.1016/j.carbpol.2020.116728. Epub 2020 Jul 6.

Abstract

Polysaccharides have aroused considerable interest due to their diverse biological activities and low toxicity. In this study, we evaluated the effect of marine polysaccharide sulfated polymannuroguluronate (TGC161) on the leukopenia induced by chemotherapy. It is found that TGC161 ameliorates the leukopenia. Besides, TGC161 would promote CD4+ T cell differentiation and maturation in the thymus, but does not have a significant effect on precursor cells in bone marrow. Furthermore, TGC161 inhibits CD4+ T cell apoptosis in vitro. Collectively, our findings offer a natural and harmless polysaccharide to ameliorate leukopenia.

Keywords: CD4(+)T cell apoptosis; Chemotherapy; Leukopenia; Sulfated polymannuroguluronate; TGC161.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • Leukopenia / immunology
  • Leukopenia / pathology
  • Leukopenia / prevention & control*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Polysaccharides / pharmacology*

Substances

  • Polysaccharides
  • sulfated polymannuroguluronate